R
Richard H. Cooke
Researcher at Virginia Commonwealth University
Publications - 35
Citations - 564
Richard H. Cooke is an academic researcher from Virginia Commonwealth University. The author has contributed to research in topics: Heart failure & Artificial heart. The author has an hindex of 13, co-authored 33 publications receiving 502 citations. Previous affiliations of Richard H. Cooke include Johns Hopkins University & VCU Medical Center.
Papers
More filters
Journal ArticleDOI
One-year outcome after combined coronary artery bypass grafting and transmyocardial laser revascularization for refractory angina pectoris
Sotiris C. Stamou,Steven W. Boyce,Richard H. Cooke,Brian D Carlos,Leslie C. Sweet,Paul J. Corso +5 more
TL;DR: In this article, the results of 30-day and 3-, 6-, and 12-month clinical follow-up after coronary artery bypass graft surgery (CABG) plus transmyocardial revascularization (TMR) were reported.
Journal ArticleDOI
The total artificial heart
Jason A. Cook,Keyur B. Shah,Mohammed A. Quader,Richard H. Cooke,Vigneshwar Kasirajan,Kris K. Rao,Melissa C. Smallfield,Inna Tchoukina,Daniel G. Tang +8 more
TL;DR: The total artificial heart (TAH) is a form of mechanical circulatory support in which the patient's native ventricles and valves are explanted and replaced by a pneumatically powered artificial heart.
Journal ArticleDOI
Primary cutaneous fungal infections in solid organ transplantation: a case series.
Peter S. Miele,Charles S. Levy,Margo A. Smith,Elizabeth M. Dugan,Richard H. Cooke,Jimmy A. Light,Daniel R. Lucey +6 more
TL;DR: Cutaneous fungal infections in solid‐organ transplant patients present in a variety of nonspecific ways, requiring a high index of suspicion to diagnose correctly and optimize the likelihood of a cure in a transplant population.
Journal ArticleDOI
Femoral vascular access-site complications in the cardiac catheterization laboratory: diagnosis and management
TL;DR: Vascular access-site complications remain a major cause of morbidity and mortality with cardiac catheterization and percutaneous intervention using the femoral approach, and alternate access sites, the use of fluoroscopic guidance, focus on anticoagulant and antiplatelet therapy, and arterial closure devices are all methods being investigated to prevent and reduce complications.
Journal ArticleDOI
Left circumflex occlusion in acute myocardial infarction (from the National Cardiovascular Data Registry).
W. Kyle Stribling,Michael C. Kontos,Antonio Abbate,Richard H. Cooke,George W. Vetrovec,David Dai,Emily F. Honeycutt,Tracy Y. Wang,Kapildeo Lotun +8 more
TL;DR: Patients with NSTEMI and occlusion have a lower mortality risk than those with STEMI, possibly because of factors such as the amount of myocardium involved, the lesion location along the vessel, and/or a dual blood supply.